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Summary 
It is now apparent that severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and coronavirus 
disease 2019 (COVID-19) will remain endemic for some time. Improved therapeutics and a vaccine may 
shorten this period, but both are far from certain. Plans must be put in place on the assumption that the 
virus and its disease will continue to impact on the care of patients and the safety of staff. This will impact 
particularly on airway management due to the inherent risk to staff during such procedures. Research is 
needed to clarify the nature and risk of respiratory aerosol-generating procedures. Improved knowledge of 
the dynamics of SARS-CoV-2 infection and immunity is also required. In the meantime, we describe the 
current status of airway management during the endemic phase of the COVID-19 pandemic. Some 
controversies remain unresolved, but the safety of patients and staff remains paramount. Current evidence 
does not support or necessitate dramatic changes to choices for anaesthetic airway management. Theatre 
efficiency and training issues are a challenge that must be addressed, and new information may enable this.  
 
Consensus airway guidelines from the Difficult Airway Society (DAS), Association of Anaesthetists, Intensive 
Care Society, Faculty of Intensive Care Medicine and Royal College of Anaesthetists (RCoA) were published 
in March 2020 [1] with paediatric guidance published in April [2]. These focus mainly on management of 
critically ill patients with confirmed or suspected coronavirus disease 2019 (COVID-19).  
 
It is now apparent that severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and COVID-19 will 
remain endemic for some time. Improved therapeutics and a vaccine may shorten this period, but both are 
far from certain. Plans must be put in place on the assumption that the virus and its disease will impact us 
and our patients. Present knowledge would suggest this will lead to: 
 Increased, and likely fluctuating demands for COVID-19-related healthcare as the prevalence of the 
disease rises and falls episodically [3]; 
 Increased risk to patients of poorer peri-operative outcome if infected with SARS-CoV-2 [4]; 
 A risk to both patient and staff of cross-infection, made more complex by the potential for disease 
transmission while asymptomatic and the difficulty in reliably identifying infected patients. 
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Aerosol-generating procedures and proportionate personal protective equipment  
Throughout June and early July 2020, the prevalence of SARS-CoV-2 in the UK decreased considerably [5]. 
There is debate as to whether current rules relating to personal protective equipment (PPE) use remain 
necessary, in particular in settings where patients have self-isolated and been screened for SARS-CoV-2 
infection before elective surgery. A recent systematic review reported that no study to date has detected 
live SARS-CoV-2 virus secretion beyond day nine of illness despite persistently high viral load, which means 
a period of self-isolation of 14 days (encompassing a ≤5 day incubation period and ≤9 days of viral 
shedding) provides considerable reassurance [Cevik M et al., Unpublished data, 
doi.org/10.1101/2020.07.25.20162107]. However, there have also been local outbreaks of infection 
causing temporary closure of hospitals in the south-west [6] and south-east [7] of England and re-
introduction of lockdown across whole cities [8]. Prevalence in the UK is currently higher than in many 
other countries. R0 is close to or above 1 in some regions and decreases in prevalence, having plateaued, 
may now be increasing [9]. Recent changes in national guidance mean that patients presenting for planned 
surgery are unlikely to have self-isolated for more than 48–72 h [10]. 
 
The evidence around which airway procedures are, or are not, aerosol-generating procedures (perhaps 
better termed aerosol-generating medical procedures), and the associated risk of infection to those 
involved, is an area in need of urgent, definitive research. At present we are reliant on syntheses of limited 
evidence and resultant national advice. Public health bodies in England, Northern Ireland, Scotland and 
Wales released an updated list of aerosol-generating procedures in early June 2020 [11], but there are no 
changes regarding airway management: face mask ventilation, tracheal intubation and extubation remain 
designated as aerosol-generating procedures and there is no guidance about supraglottic airway (SGA) use. 
The intubateCOVID study [12] reported that approximately 10% of those involved in tracheal intubation of 
patients with confirmed or suspected COVID-19 subsequently developed symptoms consistent with SAR-
CoV-2 infection or a positive antigen test, despite the vast majority of involved staff wearing airborne 
protection PPE [13]. However, whether performing these procedures and subsequent evidence of infection 
is an association or is linked causally remains uncertain.  
 
The Association of Anaesthetists and the RCoA via the Anaesthesia-Intensive Care Medicine hub website 
have provided guidance on PPE use for airway management in general [14]; in obstetric anaesthesia care 
[15]; and during paediatric anaesthesia [2]. This guidance remains in place but has been supplemented by 
additional guidance on maintaining staff safety while trying to improve theatre efficiency [16]. Professional 
guidance has also been issued on appropriate aerosol clearance times to be adhered to after aerosol-
generating procedures, and particularly after airway management at the beginning and end of general 
anaesthesia [17]. Adherence to the appropriate number of aerosol clearance times – most likely five 
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promote both staff safety and theatre efficiency. This fallow time is not necessary before the patient or 
staff may leave the room [16].  
 
If the prevalence of SARS-CoV-2 in the community and hospitals continues to decrease, guidance will need 
to be updated. Decisions to modify precautions, such as using anaesthetic rooms and altering or stopping 
the use of PPE, are complex due to the dynamic and uncertain nature of the situation. Any decision to stop 
using PPE, initially selectively and then in general, should be led by national and local decision-making, and 
guidance on this process has been issued [18]. Airborne precaution PPE is indicated for an aerosol-
generating procedure and it is not logical to use droplet precaution PPE for protection against aerosols, as 
this protects against the wrong mode of disease transmission [13].  
 
Choices in airway management 
Fundamentals of airway management have not changed as a result of COVID-19 but there is perhaps now, 
even more than previously, a focus on use of personnel, equipment and techniques that achieve successful 
and safe airway management at the first attempt.  
 
When regional anaesthesia is appropriate, avoidance of general anaesthesia obviates the need for airway 
aerosol-generating procedures and may decrease risk to staff while improving theatre efficiency [19]. 
Informed patient consent will, as usual, require an open discussion and explanation of benefits and risks for 
patient and staff [20].  
 
There is a lack of clear evidence regarding the degree of risk to staff of exposure to aerosolised virus during 
airway management with a tracheal tube or a SGA, and whether these differ. In the absence of such 
evidence it remains a clinical judgement whether a tracheal tube or SGA is used, but COVID-19 should not 
be a major driver to change routine practice. 
 
Airway assessment 
Since the COVID-19 outbreak, face-to-face consultations have been actively discouraged and many 
interactions are now virtual. This has the potential to impact on the opportunities for, and accuracy of, 
airway assessment, in particular of patients in whom airway difficulty is an increased risk. It is too early to 
know whether this will impact on the number of unexpected difficulties encountered during airway 
management. As a result of the emphasis on limiting the number and duration of aerosol-generating 
procedures, airway assessment should not be limited to identification of potential difficulty with 
laryngoscopy, and particular attention should be paid to identifying factors that may decrease safe apnoea 
time or predict difficulty in facemask ventilation. Optimising the quality of remote airway assessment and 
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Pre-oxygenation and per-oxygenation – extending safe apnoea time  
Prolonging safe apnoea time is a mainstay of safe airway management but in the COVID-19 setting may also 
reduce the need for facemask ventilation and other aerosol-generating procedures. Measures to prolong 
safe apnoea time are advisable in all patients before general anaesthesia but particularly in those patients 
in whom either difficult airway management or a short safe apnoea time is predicted.  
 
Meticulously applied, standard pre-oxygenation methods are suitable for most patients. The threshold for 
use of low-flow nasal oxygen during airway management should be lowered as this may effectively delay 
oxygen desaturation and obviate the need for other interventions [21]. 
 
High-flow humidified nasal oxygen remains on the UK public health organisations list of aerosol-generating 
procedures [11] but the evidence base for this is not conclusive and its inclusion is likely precautionary [22]. 
Use of high-flow nasal oxygen should be considered relatively rather than absolutely contraindicated. 
Where a patient’s risk of hypoxaemia during anaesthetic care is significant, and rapid arterial oxygen 
desaturation would necessitate other, perhaps riskier, aerosol-generating procedures, an individual risk-
benefit assessment may favour the use of high-flow nasal oxygen. If high-flow nasal oxygen is used, 
airborne precaution PPE should be worn.  
 
Facemask ventilation 
Facemask ventilation is currently considered to be an aerosol-generating procedure. The extent of aerosol 
generation will logically depend on factors that include the extent of (poor) airway seal; the peak airway 
pressure; duration of facemask ventilation; and any episodes of mask removal. Assessment of all patients is 
important to identify and plan for those in whom facemask ventilation may be difficult, as difficult 
facemask ventilation is likely to be associated with increased airway leak.  
 
When facemask ventilation is used, a technique that minimises risk of leak should be adopted. This includes 
optimal airway positioning (sniffing or ‘flextension’ [23]) and airway manoeuvres (chin lift and jaw thrust), 
adequate anaesthesia and early use of an oropharyngeal airway. Capnography during facemask ventilation 
is useful in assessing adequacy of ventilation and airway leak [24]: when the airway is clear and sealed, 
facemask ventilation should produce a capnogram with normal shape and a plateau.  Loss of the plateau 
and reduction in detected exhaled carbon dioxide progressively indicates worsening ventilation from 
airway leak or obstruction. There should be early recourse to optimising manoeuvres: handing over to a 
more experienced clinician; repositioning; use of a ‘VE hand’ position (‘vice grip’ [23]); use of a two-person 
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Videolaryngoscopy in routine practice 
Consensus UK COVID-19 airway management guidelines advocate videolaryngoscopy as the default 
technique for tracheal intubation [1]. Early data from the intubateCOVID study indicate this has been 
widely used and first-pass success rates were high in challenging situations [12]. The reasons to use 
videolaryngoscopy in a COVID-19 setting have not changed and include (compared with direct 
laryngoscopy) improved view at laryngoscopy; reduced likelihood of difficult or failed intubation; improved 
first-pass success; and increased distance between the intubator and patient [25,26]. Despite a likely 
increase in access to videolaryngoscopy, as anaesthetic and surgical activity increases it may be that some 
will not have capacity for universal use of videolaryngoscopy and some may choose not to use it.  
 
Supraglottic airways 
Guidance has been published on the Anaesthesia-Intensive Care Medicine hub website about use of SGAs 
in the COVID-19 setting [27] and this is also discussed in guidance on optimising operating theatre 
processes [16]. There remains uncertainly as to whether insertion, removal or ventilation via a SGA 
generates aerosols. It is anticipated that research will soon shed light on this. A Scottish review of aerosol-
generating procedures (on which evidence the UK public health organisations have updated the core 
aerosol-generating procedure list) concluded that there was no evidence that SGA insertion is an aerosol-
generating procedure, but conversely presented no evidence that it is not [28].  
 
We summarise our consensus view at present, which may be updated in the event of new evidence (Fig. 1). 
 
 The act of inserting or carefully removing a SGA is unlikely to create aerosols. However, other necessary 
procedures (facemask ventilation; airway suction; reverting to tracheal intubation) or patient actions 
(coughing) may generate aerosols and these occur unpredictably during SGA insertion and removal. 
Therefore, SGA insertion and removal should be planned for as if it were an aerosol-generating 
procedure. Coughing during removal of a SGA is less common than for a tracheal tube [29,30]. 
 If none of the above associated events occurs, SGA insertion and removal may be treated as not being 
an aerosol-generating procedure (but only after the event). This may improve theatre efficiency by 
reducing delays dependent on others’ use of PPE and waiting for five aerosol clearance times to elapse 
before others enter the theatre. 
 Use of a SGA when there is a good airway seal during maintenance will logically be no more likely to 
create an aerosol than would ventilation via a tracheal tube. However, if there is a leak, there may be 
potential to generate aerosols. It should usually be evident at or soon after insertion whether a good 
airway seal has been achieved. Capnography and anaesthetic machine spirometry loops can be 
particularly useful in identifying leaks. 
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o Patient: size; shape; airway anatomy; lung and chest wall compliance; position during surgery. 
o Device: design (most second-generation SGAs perform better than most first-generation devices 
[31]); correct sizing. 
o Mode of ventilation: airway leak is less likely during spontaneous ventilation, but patient 
movement or coughing during light anaesthesia increases risk of leak; during controlled ventilation, 
lower peak airway pressures minimise leak. 
o Anaesthetist: knowledge; experience; technique; performance.  
o Surgery: need for access to the airway or head and neck; patient position or surgical procedures 
that alter lung compliance. 
o Other factors: neuromuscular blockade is unlikely to improve airway seal routinely but may help in 
some cases [32]. 
 
Awake tracheal intubation 
Awake tracheal intubation techniques were likely used less frequently during the pandemic surge. As more 
routine surgical activity is undertaken, the number of cases for which it is now indicated will increase. This 
particularly includes head and neck cancer surgery, where delayed presentations and challenging airways 
may be more common as a result of the pandemic. The indications for awake tracheal intubation are 
generally the same with or without COVID-19, and avoiding awake techniques in such patients in order to 
protect staff may put patients at risk. 
 
Local anaesthesia and sedation techniques that minimise coughing are recommended. These include 
nebulised local anaesthesia before arriving in theatre; using antitussive agents such as remifentanil before 
topicalisation; slow and precise topicalisation with adequate time between sprays; maintaining appropriate 
distancing from the patient; and avoidance of cough-generating techniques such as administering 
intratracheal local anaesthesia.  Due to the proximity between intubator and the patient and the potential 
for coughing, awake tracheal intubation should be considered an aerosol-generating procedure. 
 
Because of the difficulty in cleaning the working channels of flexible optical bronchoscopes, single-use 
devices have potential benefits and are recommended provided the device’s quality is sufficient and 
broadly similar to an available reusable device.  
 
Use of innovative equipment 
As “necessity is the mother of invention”, the challenges posed by the pandemic have led to several 
innovations designed to reduce the risk of operator exposure to viral aerosols during airway manoeuvres – 
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The most obvious example of this in adult practice has been a clear Perspex® ‘aerosol box’ [33] (of which 
there are numerous variations) designed to prevent dispersal of virus-containing droplets and aerosols. 
Other examples are use of plastic isolating sheets or enclosures over the face, especially of children during 
tracheal intubation, and the use of suction or extractor hoods placed close to the patient’s airway [34-7]. 
These have been prominent on social media, but the extent of clinical use is unknown. In the case of the 
aerosol box, one evaluation [38] has shown it to hinder the tracheal intubation process; reduce tracheal 
intubation success; and risk or cause damage to PPE. A second study suggested its potential to increase 
exposure to exhaled particles [36] and a third suggested failure of the box to contain the aerosol [39]. 
 
It is likely that some innovative practices may provide benefit. However, there is also the potential for 
harm, some of which may be from unintended consequences. The principles of airway management 
promoted in the consensus UK COVID-19 airway management guidelines are safe, accurate and swift (SAS) 
airway management [1]. Accuracy refers to use of techniques and equipment that has been evaluated and 
shown to be effective and reliable, enabling first time success. The use of innovations that have not been 
evaluated goes against these SAS principles. It may also have legal implications if there is harm to patients 
or staff. While we support innovation, we do not support use of unevaluated innovations [40].  
 
Paediatric considerations 
The incidence of COVID-19 in children requiring hospitalisation in the UK remains very low, with only a 
small number requiring intensive care admission and very low mortality in children [41,42]. A small number 
have been affected by the rare paediatric multisystem inflammatory syndrome, temporally associated with 
COVID-19 [43]. Consensus guidelines for managing the airway in children with COVID-19 remain unchanged 
from those published in April 2020 [2].  
 
During the pandemic, suspension of most elective surgical work has had significant repercussions in 
paediatric surgery and anaesthesia. Many district general hospitals diverted their paediatric emergencies to 
tertiary centres. It is likely that this surgery will soon be repatriated and that elective paediatric surgery will 
recommence.  
 
The Royal College of Paediatrics and Child Health has recently published guidance on elective surgery in 
children [44]. This proposes use of local prevalence data to drive pre-operative management, with this 
categorised as red (prevalence rate > 2%); amber (≥ 0.5% and < 2%); or green (< 0.5%). During amber and 
green periods the guidance concludes that (disruptive and often poorly complied with) child and family 
isolation will provide little benefit and recommends that pre-operative isolation of children and their 
parents is not required. Changes in national or local activity will trigger altered peri-operative processes. 
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Management of attending parents and carers differs little from normal. A parent or carer who is 
asymptomatic can be present at induction and should leave before any aerosol-generating procedure. The 
parent or carer should wear a face covering or droplet protection PPE in theatre. 
 
Obstetric anaesthesia 
The unpredictable timing of childbirth makes it a major challenge to identify and separate obstetric patients 
into cohorts of higher and lower risk of SARS-CoV-2 infection, although this may be possible for planned 
procedures. Better testing procedures, including more rapid turnover and greater reliability of results, may 
improve the situation, but it is likely that precautions against SARS-CoV-2 transmission will need to remain 
longer in obstetric settings than others. Recommendations for obstetric anaesthesia care for patients with 
COVID-19 have been published elsewhere [45]. 
 
Part of good obstetric care in normal circumstance involves avoiding general anaesthesia when possible, 
and this is likely particularly true in the COVID-19 setting. Measures to achieve this include: 
 
 Good communication and planning between anaesthetist, patient, midwives and the obstetric team, 
including the management of suboptimal regional anaesthesia; 
 Informing women with symptomatic or confirmed COVID-19 [46] who are in early labour about the 
potential benefit of epidural analgesia in minimising the need for general anaesthesia if urgent 
intervention for birth is needed so that they can make informed decisions regarding use or type of 
labour analgesia and anaesthesia; 
 Optimal fetal resuscitation in cases of fetal distress. 
 
The remote location of many delivery suites, the frequently urgent nature of care and the high cognitive 
demands create challenging circumstances when delivering general anaesthesia for a pregnant woman 
suspected or known to be SARS-CoV-2 infected. Help from a senior anaesthetist, particularly out of hours, 
may be delayed due to remote location and the need to don PPE. Some departments advocate having two 
anaesthetists available for COVID-19 positive cases. There should always be clear lines of communication 
about who to call and how to contact them [47]. 
 
General anaesthesia and rapid sequence induction should follow the principles in the consensus UK COVID-
19 airway management guidelines [1]. The checklist within these guidelines was designed to be adaptable 
to local need and an example of adaptation for obstetric rapid sequence induction is shown in Figure 2. Use 
of such a checklist may be suitable for planned obstetric interventions but is too detailed for category 1 
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organisation to ensure readiness for such cases. In the event of a failed intubation, the decision to proceed 
with surgery or awaken the mother should follow the 2015 Obstetric Anaesthetists' Association and DAS 
obstetric intubation guidelines [48]. 
 
Patients with a tracheostomy  
Performance of tracheostomy and open tracheal suction (e.g. via a tracheostomy) are included in 
mainstream lists of aerosol-generating procedures. Tracheostomy tube care, cuff care and tube changes all 
also have the potential for aerosol generation. There is therefore a need for clear protocols when 
undertaking tracheostomy formation, anaesthetising a patient with a tracheostomy or managing 
tracheostomies on the wards.  
 
During the COVID-19 pandemic it is likely that a greater proportion of tracheostomies in the critically ill will 
be performed in theatres using an open surgical technique. Use of a cuffed non-fenestrated tracheostomy 
tube is recommended. Guidance has been issued on the timing and management of tracheostomy 
formation in this setting [49]. ENT-UK, collaborating with other organisations, has published a framework 
for open tracheostomy in COVID-19 patients [50]. This guidance emphasises the importance of 
collaboration between anaesthetist and surgeon when the trachea is open during tracheostomy and while 
exchanging the orotracheal tube for a tracheostomy tube. Pre-oxygenating, advancing the tracheal tube 
beyond the surgical site and stopping ventilation during the open tracheal and tube exchange phases are all 
strategies to reduce aerosol generation in the surgical field. 
 
An extensive range of COVID-19 tracheostomy resources is available at the National Tracheostomy Safety 
Project website (http://www.tracheostomy.org.uk/healthcare-staff/improving-tracheostomy-care/covid-
19) including professional multidisciplinary guidance for adult and paediatric practice and information for 
patients and carers. 
 
Training in airway management – guidance for novice airway training 
In the UK each year more than 1000 trainees undertake training in anaesthesia and are required to 
complete an ‘initial assessment of competence’. Of these, approximately 600 come through training paths 
that lead to continuing anaesthetic training. The remainder will exit to emergency medicine (around 360 
per year) or acute medicine training pathways. Similar training pressures will exist outside the UK. 
 
The knowledge and skills required to complete the UK initial assessment of competence are outlined in the 
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• Maintaining the airway with oral/nasopharyngeal airways;  
• Ventilating the lungs with a bag and mask;  
• Inserting and confirming placement of a SGA; 
• Successfully placing nasal/oral tracheal tubes using direct laryngoscopy; 
• Correctly conducting rapid sequence induction. 
 
The trainee must be assessed as competent in these skills as part of the initial assessment of competence 
before undertaking general anaesthesia without direct supervision. All training required to complete the 
initial assessment of competence is undertaken in a supernumerary capacity, which places considerable 
demands on anaesthetic departments.  
 
Several factors have had a detrimental impact on departments’ ability to undertake novice training during 
the COVID-19 pandemic. The consensus UK COVID-19 airway management guidelines advocate 
videolaryngoscopy as a default intubation technique [1], and this has been widely adopted. These 
guidelines also advocate airway management being undertaken by the most senior anaesthetist. Finally, 
the volume of elective NHS surgical activity has decreased considerably, and some of this is now being 
undertaken in non-NHS hospitals.  
 
There is therefore a risk that doctors in training in the coming year will be unable to gain sufficient clinical 
experience to develop the skills required for successful completion of the initial assessment of competence. 
This is particularly important for those groups of trainees who will spend only a few months in an 
anaesthetic attachment. In the UK, successful completion of the initial assessment of competence is a 
mandatory requirement for this group and failure to achieve it within their anaesthetic placements will 
necessitate additional training time and further impact on training capacity in the future. 
 
Measures to support training 
The RCoA and DAS have worked in partnership to produce this guidance to support both trainees and 
trainers in the training period before the initial assessment of competence. Some departments will already 
have made plans locally to address the issue of increased pressure on new start trainee airway training. The 
following measures are essential to support skills-development in the current climate. 
 
 Simulation should be used to augment clinical experience and promote airway skills acquisition.  
 Clinical schedules should be adapted specifically to enable delivery of both in-theatre training and 
simulation to those doctors in training who need to complete the initial assessment of competence. 
 Appropriate training facilities should be established, both in terms of physical space and equipment, to 
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 Videolaryngoscopy can be used as an alternative to direct laryngoscopy for training and assessment in 
tracheal intubation in clinical settings. However, all trainees must be able to demonstrate competence 
in direct laryngoscopy in simulated settings to successfully complete the initial assessment of 
competence. 
 
All departments must have a comprehensive plan to ensure that airway training can be optimised in the 
coming year to ensure successful completion of the initial assessment of competence. This should be 
agreed with the College Tutor and departmental Airway Lead. A teaching package from DAS and the RCoA 
for the delivery of simulation airway training to novice trainees in preparation for the initial assessment of 
competence is available on the DAS website [52].  
 
Conclusions 
The pandemic has entered a phase of endemic infection and the consequences of this will impact 
healthcare for a significant period. This creates a dynamic situation during which both the course of the 
pandemic and the success of global responses to it are uncertain. Research is needed to clarify the nature 
and risk to staff of aerosol-generating procedures. Improved knowledge of the dynamics of SARS-CoV-2 
infection and immunity to it are required. In the meantime, this document outlines the current status of 
airway management within the COVID-19 pandemic. Some controversies remain unresolved, but the safety 
of patients and staff remains paramount. Current evidence does not support or necessitate dramatic 
changes to choices for anaesthetic airway management. Theatre efficiency and training issues are a 
challenge that must be addressed to enable efficient delivery of healthcare, and new information may 
enable this. A collaborative approach between the relevant anaesthetic bodies remains an important way 
to maintain and enhance standards in airway management. 
 
Acknowledgements 
TC’s department has received free or at cost airway equipment from numerous airway device 
manufacturers for evaluation or research. He has spoken at educational events organised by Covidien, Storz 
GmBh and Fisher and Paykel but has not been paid for any of these. No funding or other competing 












This article is protected by copyright. All rights reserved 
References 
1. Cook TM, El‐Boghdadly K, McGuire B, McNarry AF, Patel A, Higgs A. Consensus guidelines for managing 
the airway in patients with COVID ‐19. Guidelines from the Difficult Airway Society, the Association of 
Anaesthetists the Intensive Care Society, the Faculty of Intensive Care Medicine and the Royal College 
of Anaesthetists. Anaesthesia 2020; 75: 785–99. 
2. Cook TM, El-Boghdadly K, McGuire B, et al. Consensus guidelines for managing the airway in children 
with COVID-19. Guidelines from the Association of Anaesthetists, the Difficult Airway Society, the 
Intensive Care Society, the Faculty of Intensive Care Medicine and the Royal College of Anaesthetists, 
Paediatric Intensive Care Society, Association of Paediatric Anaesthetists. April 2020. 
https://static1.squarespace.com/static/5e6613a1dc75b87df82b78e1/t/5e8b0a6406e7117ae541572a/1
586170470089/Paediatric-Airway-Guidelines_01.04.20.pdf (accessed 10/08/2020). 
3. Pandit JJ. Demand–capacity modelling and COVID‐19 disease: identifying themes for future NHS 
planning. Anaesthesia 2020. Epub 21 May. https://doi.org/10.1111/anae.15144 
4. COVIDSurg Collaborative. Mortality and pulmonary complications in patients undergoing surgery with 
perioperative SARS-CoV-2 infection: an international cohort study. Lancet 2020; 396: 27–38.  
5. Office for National Statistics. Coronavirus (COVID-19) Infection Survey pilot: England, 24 July 2020. 
https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/
bulletins/coronaviruscovid19infectionsurveypilot/england24july2020 (accessed 10/08/2020). 
6. BBC News. Coronavirus: Weston hospital 'to be shut for at least a week'. 28 May 2020. 
https://www.bbc.com/news/uk-england-somerset-52830447 (accessed 10/08/2020). 
7. BBC News. Coronavirus: Hillingdon Hospital shuts to emergencies after outbreak. 8 July 2020. 
https://www.bbc.co.uk/news/uk-england-london-53335584 (accessed 10/08/2020). 
8. BBC News. Leicester lockdown: 'Shocked' residents prepare for new restrictions. 30 June 2020. 
https://www.bbc.co.uk/news/uk-england-leicestershire-53237059  (accessed 10/08/2020). 
9. Office for National Statistics. Coronavirus (COVID-19) Infection Survey pilot: England, 31 July 2020. 
https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/
bulletins/coronaviruscovid19infectionsurveypilot/31july2020 (accessed 10/08/2020). 
10. National Institute for Health and Care Excellence. COVID-19 rapid guideline: arranging planned care in 
hospitals and diagnostic services NICE guideline [NG179]. 27 July 2020. 
https://www.nice.org.uk/guidance/NG179 (accessed 10/08/2020). 













This article is protected by copyright. All rights reserved 
12. El‐Boghdadly K, Wong DJN, Owen R, et al. Risks to healthcare workers following tracheal intubation of 
patients with COVID‐19: a prospective international multicentre cohort study. Anaesthesia 2020. Epub 
9 June. https://doi.org/10.1111/anae.15170 
13. Cook TM. Personal protective equipment during the coronavirus disease (COVID) 2019 pandemic – a 
narrative review. Anaesthesia 2020; 75: 920–7. 
14. Cook TM, Harrop-Griffiths W. Updated guidance on Personal Protective Equipment (PPE) for clinicians. 
April 2020. https://icmanaesthesiacovid-19.org/personal-protective-equipment-ppe-for-clinicians 
(accessed 10/08/2020). 
15. Lucas N, Bamber J, Donald F, Platt F. Updated advice regarding PPE to be worn when managing 
pregnant women with known or suspected COVID-19. April 2020. https://icmanaesthesiacovid-
19.org/advice-regarding-ppe-to-be-worn-when-managing-pregnant-women-with-known-or-suspected-
covid19 (accessed 10/08/2020). 
16. Cook TM, Ferguson K, Johannsson H, Harrop-Griffiths W. Managing theatre processes for planned 
surgery between COVID-19 surges. June 2020. https://icmanaesthesiacovid-19.org/managing-theatre-
processes-for-planned-surgery-between-covid-19-surges (accessed 10/08/2020). 
17. Cook TM, Harrop-Griffiths W. Aerosol clearance times to better communicate safety after aerosol‐
generating procedures. Anaesthesia 2020; 75: 1122–3. 
18. Intensive Care Society, Faculty of Intensive Care Medicine, Association of Anaesthetists, Royal College 
of Anaesthetists. PPE guidance during planned surgery restarts. Clarification of issued guidance. June 
2020. 
https://static1.squarespace.com/static/5e6613a1dc75b87df82b78e1/t/5ef34a0943255a5168d58e46/1
593002505738/Clarification-guidance-during-planned-surgery-restarts.pdf (accessed 10/08/2020). 
19. Uppal V, Sondekoppam RV, Landau R, El‐Boghdadly K, Narouze S, Kalagara HKP. Neuraxial anaesthesia 
and peripheral nerve blocks during the COVID‐19 pandemic: a literature review and practice 
recommendations. Anaesthesia 2020. Epub 28 April. https://doi.org/10.1111/anae.15105 
20. Macfarlane AJR, Harrop-Griffiths W, Pawa A. Regional anaesthesia and COVID-19: first choice at last? 
British Journal of Anaesthesia 2020. Epub 28 May. https://doi.org/10.1016/j.bja.2020.05.016 
21. Gleason JM, Christian BR, Barton ED. Nasal cannula apneic oxygenation prevents desaturation during 
endotracheal intubation: an integrative literature review. Western Journal of Emergency Medicine 
2018; 19: 403–11. 
22. Lyons C, Callaghan M. The use of high‐flow nasal oxygen in COVID ‐19. Anaesthesia 2020; 75: 843–7. 
23. Chrimes N. Troubleshooting mask ventilation. http://vortexapproach.org/lifelines#fmv (accessed 
10/08/2020). 











This article is protected by copyright. All rights reserved 
25. Lewis SR, Butler AR, Parker J, Cook TM, Smith AF. Videolaryngoscopy versus direct laryngoscopy for 
adult patients requiring tracheal intubation. Cochrane Database of Systematic Reviews 2016; 11: 
CD011136. 
26. Pieters BMA, Maas EHA, Knape JTA, van Zundert AAJ. Videolaryngoscopy vs. direct laryngoscopy use by 
experienced anaesthetists in patients with known difficult airways: a systematic review and meta‐
analysis. Anaesthesia 2017; 72: 1532–41. 
27. Cook TM, Ferguson K, McGuire B, Harrop-Griffiths W. Use of supraglottic airways during the COVID-19 
pandemic. https://icmanaesthesiacovid-19.org/use-of-supraglottic-airways-during-the-covid-19-
pandemic (accessed 10/08/2020). 
28. Health protection Scotland. SBAR: Assessing the evidence base for medical procedures which create a 
higher risk of respiratory infection transmission from patient to healthcare worker. 12 May 2020 
https://hps.scot.nhs.uk/web-resources-container/sbar-assessing-the-evidence-base-for-medical-
procedures-which-create-a-higher-risk-of-respiratory-infection-transmission-from-patient-to-
healthcare-worker/ (accessed 10/08/2020). 
29. Nicholson A, Cook TM, Smith AF, Lewis SR, Reed SS. Supraglottic airway devices versus tracheal 
intubation for airway management during general anaesthesia in obese patients. Cochrane Database 
Systematic Reviews 2013; 9: CD010105.  
30.  Park SK, Ko G, Choi GJ, Ahn EJ, Kang H.  Comparison between supraglottic airway devices and 
endotracheal tubes in patients undergoing laparoscopic surgery: A systematic review and meta-
analysis. Medicine (Baltimore) 2016; 95: e4598. 
31. Cook TM, Kelly FE. Time to abandon the ‘vintage’ LMA and adopt 2nd generation SADs as 1st choice. 
British Journal of Anaesthesia 2015; 115: 497–9. 
32. Goldmann K, Hoch N, Wulf H. Influence of neuromuscular blockade on the airway leak pressure of the 
ProSeal laryngeal mask airway. Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie 2006; 
41: 228–32.  
33. Hsu SH, Lai HY, Zabaneh F, Masud FN. Aerosol containment box to the rescue: extra protection for the 
front line. Emergency Medicine Journal 2020; 37: 400–1. 
34. Yang YL, Huang CH, Luk HN, Tsai PB. Adaptation to the plastic barrier sheet to facilitate intubation 
during the COVID-19 pandemic. Anesthesia and Analgesia: 2020; 131: e97–e99 
35. Bryant J, Tobias JD. Enclosure with augmented airflow to decrease risk of exposure to aerosolized 
pathogens including coronavirus during endotracheal intubation. Can the reduction in aerosolized 
particles be quantified? Pediatric Anaesthesia 2020. Epub 28 May. https://doi.org/10.1111/pan.13934  
36. Simpson JP, Wong DN, Verco L, Carter R, Dzidowski  M, Chan PY. Measurement of airborne particle 
exposure during simulated tracheal intubation using various proposed aerosol containment devices 










This article is protected by copyright. All rights reserved 
37. Matava C, Collard V, Siegel J, Fiset P, Engelhardt T. Use of a high-flow extractor to reduce aerosol 
exposure. British Journal of Anaesthesia 2020. Epub 28 July. https://doi.org/10.1016/j.bja.2020.07.014 
38. Begley JL, Lavery KE, Nickson CP, Brewster DJ. The aerosol box for intubation in coronavirus disease 
2019 patients: an in‐situ simulation crossover study. Anaesthesia 2020; 75: 1014–21. 
39. Jazuli F, Bilic M, Hanel E, Ha M, Hassall K, Trotter BG. Endotracheal intubation with barrier protection. 
Emergency Medicine Journal 2020; 37: 398–9. 
40. Turner MC, Duggan LV, Glezerson BL, Marshall SD. Thinking outside the (acrylic) box: a framework for 
the local use of custom‐made medical devices. Anaesthesia 2020. Epub 29 May. 
https://doi.org/10.1111/anae.15152 
41. Royal College of Paediatrics and Child Health. COVID-19 - service evaluation and audit on the care 
needs of children admitted to hospital (England). August 2020. 
https://www.rcpch.ac.uk/resources/covid-19-service-evaluation-audit-care-needs-children-admitted-
hospital-england (accessed 10/08/2020). 
42. Götzinger F, Santiago-García B, Noguera-Julián A, et al. COVID-19 in children and adolescents in Europe: 
a multinational, multicentre cohort study. Lancet Child and Adolescent Health 2020. Epub 25 June. 
https://doi.org/10.1016/S2352-4642(20)30177-2 
43. Royal College of Paediatrics and Child Health. Guidance - Paediatric multisystem inflammatory 
syndrome temporally associated with COVID-19 (PIMS). May 2020. 
https://www.rcpch.ac.uk/resources/guidance-paediatric-multisystem-inflammatory-syndrome-
temporally-associated-covid-19-pims (accessed 10/08/2020). 
44. Royal College of Paediatrics and Child Health. National guidance for the recovery of elective surgery in 
children. August 2020. https://www.rcpch.ac.uk/resources/national-guidance-recovery-elective-
surgery-children (accessed 10/08/2020). 
45. Bampoe S, Odor PM, Lucas DN. Novel coronavirus SARS-CoV-2 and COVID-19. Practice 
recommendations for obstetric anaesthesia: what we have learned thus far. International Journal of 
Obstetric Anaesthesia. 2000; 43: 1-8 
46. Royal college of Obstetricians and Gynaecologists. Coronavirus (COVID-19) infection and pregnancy. 24 
July 2020. https://www.rcog.org.uk/en/guidelines-research-services/guidelines/coronavirus-
pregnancy/ (accessed 10/08/2020). 
47. Royal College of Anaesthetists. Cappuccini Test. https://rcoa.ac.uk/safety-standards-quality/guidance-
resources/cappuccini-test (accessed 10/08/2020). 
48. Mushambi MC, Kinsella SM, Popat M. Obstetric Anaesthetists' Association and Difficult Airway Society 
guidelines for the management of difficult and failed tracheal intubation in obstetrics. Anaesthesia 
2015; 70: 1286–306. 












This article is protected by copyright. All rights reserved 
50. ENTUK. Framework for open tracheostomy in COVID-19 patients. 2020. 
http://www.tracheostomy.org.uk/storage/files/ENT_UK%20COVID%20tracheostomy%20guidance_com
pressed.pdf  (accessed 17/08/2020). 
51. Royal College of Anaesthetists. CCT in Anaesthetics - Core Level Training.  
https://www.rcoa.ac.uk/documents/cct-anaesthetics-core-level-training/glossary-terms  (accessed 
10/08/2020). 
52. Difficult Airway Society. An Introduction to Airway Management - Teaching Material for Novice Airway 





Figure 1. Aerosol generation during supraglottic airway (SGA) use: risk factors and considerations. 
AGP, aerosol-generating procedure. 
 
 
Figure 2. An example of a checklist suitable for use before a planned rapid sequence induction for a 
pregnant patient with or suspected to have coronavirus disease 2019 (COVID-19). Adapted from the 
original consensus UK COVID-19 airway management guidelines [1].  
RSI, rapid sequence induction; PPE, personal protective equipment; FFP, filtering facepiece; eFONA, 
emergency front-of-neck airway; HME, heat and moisture exchanger;  SGA, supraglottic airway; OAA, 
Obstetric Anaesthetists Association; SpO2, pulse oximetry; ECG, electrocardiogram; iv, intravenous; ETO2, 
end-tidal oxygen; NIV, non-invasive ventilation; HFNO, high-flow nasal oxygen; CTG, cardiotocograph; GA, 















• Facemask ventilation 
• Airway suction 
• Multiple attempts 
• Change to tracheal intubation
AGP if risk factor occurs
Low risk if none occur
Maintenance
• Patient features 
• Device used 
• Mode of ventilation 
• Anaesthetist 
• Surgery 
• Neuromuscular blocking drugs
Low risk unless airway leak 
present
Removal
• Facemask ventilation 
• Suction 
• Revert to tracheal intubation 
• Coughing
AGP if risk factor occurs










Prepare EquipmentPersonal Protective Equipment In the RoomPrepare for Difficulty
Post-procedure and 
Safety
PPE – be thorough, don’t rush
q Wash hands
q Buddy with checklist
q Put on PPE 
q Long sleeved gown
q FFP3 (or equivalent) mask
q Gloves
q Eyewear
q Headwear and wipeable shoes as 
per local protocol
q Final buddy check
q Names on visors
q Allocate roles:
A: Team leader and intubator
B: Cricoid force and intubator’s 
assistant
C: Drugs, monitor, timer
D: Runner (outside)
Decide who will do eFONA
q How does runner contact further help 
if required?
q Check kit (kit dump)







q Tracheal tubes x2
q Ties and syringe
q In-line suction ready
q Tube clamp
q 2nd generation SGA
q eFONA set available
q Do you have all the drugs required?
q Induction drug, with 2nd syringe   
ready 
q Propofol 2–4 mg.kg–1









q Is airway difficulty anticipated? If 
so call for help






q Checked IV access 
q Antacid given
q Optimise position
q Consider ramping or reverse 
Trendelenburg
q Left bed tilt
q Optimal pre-oxygenation
q ≥ 3 min or ETO2 > 85%
q Consider low-flow (5 l.min–1) O2
for apnoeic oxygenation (No NIV, 
no HFNO)
q Assistant ready to apply cricoid force?
q Before starting 
q Review CTG
q Confirm GA still indicated
q Now proceed
q If the airway is difficult, should we 
wake the patient up? Use OAA 
decision chart
q VERBALISE the plan for a difficult 
intubation?
Plan A: RSI
Plan B/C: 2-handed 2-person mask 
ventilation & 2nd generation SGA
Plan D: Front of neck airway: scalpel 
bougie tube
q Extubation plan
q Confirm agreed plan
q Does anyone have any concerns?
q Airway management
q Inflate cuff before any ventilating
q Check waveform capnography
q Push/twist connections
q Clamp tracheal tube before any 
disconnection
q Avoid unnecessary disconnections
q Extubation
q Prepare, plan, position
q NMJ function monitored
q Fully reversed
q Minimise noise
q Minimise aerosol generation
q Careful equipment disposal
q Decontamination of reusable equipment
q Complete and display intubation form
q Remove PPE
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